Author
Listed:
- Ashwini De Silva
(University of Melbourne)
- Alexander van Heusden
(University of Melbourne)
- Zhongyu Lang
(Erasmus University)
- Nancy Devlin
(University of Melbourne)
- Richard Norman
(Curtin University)
- Kim Dalziel
(University of Melbourne)
- Tessa Peasgood
(University of Melbourne
University of Sheffield)
- Tianxin Pan
(University of Melbourne)
Abstract
Objectives This systematic review examines how different perspectives influence the valuation of child health-related quality of life (HRQoL). Specifically, it explores differences in values when health states are assessed by children, adolescents, or adults (or some combination of these), from the perspective of the first person (self) or the third person (other), and whether specifying (or not) the age of the person living the described health state affects the valuations. Recent studies suggest discrepancies for descriptively similar health states potentially owing to differences in respondents’ willingness to trade length-of-life for quality-of-life for children, though findings are inconsistent. This review aims to assess: (1) differences in peoples’ willingness to trade, (2) differences between the relative importance of dimensions, and (3) factors influencing these differences. Methods This systematic review follows PRISMA guidelines. A search in Ovid MEDLINE, Ovid Embase, and EconLit up to November 2024 was undertaken. We included studies where different perspectives and different valuation instruments were considered. We extracted information on study characteristics, instruments, valuation methods, perspective, study design, analytical methods, sample characteristics, differences in values by respondents, and perspective. A multi-level meta-regression assessed the impact of factors affecting the mean differences between perspectives. Results In total, 24 studies were included, which were from 2004 to 2024. Studies used a range of preference elicitation methods and nearly half (38%) used mixed valuation methods. Most studies (71%) used the EQ- 5D-Y- 3L instrument. Overall, 54% of studies compared adults valuing health states for themselves, or other adult versus adults valuing for other children or themselves as children. The multi-level meta-regression found that the severity of the health state and the valuation method has a significant impact on the mean differences between child and adult values for child health states. In most of the studies when adults are respondents, pain or discomfort was considered as the most important dimension. When adolescent respondents value health states the results are mixed. Qualitative studies identified respondents’ difficulty imagining a child in ill health and becoming emotional while thinking about child poor health and early death as potential reasons behind differences in child values versus adult values. Conclusions The evidence suggests that differences in mean values arise when different perspectives are used in valuing severe child health states by adults. These differences are influenced by factors such as health state severity and valuation method. While the review identified the key factors influencing the differences in mean values, an uncertainty remains regarding the optimal choice of preference elicitation and anchoring methods for child health state valuations. Addressing these gaps could refine future valuation methods for child health-related quality-of-life instruments.
Suggested Citation
Ashwini De Silva & Alexander van Heusden & Zhongyu Lang & Nancy Devlin & Richard Norman & Kim Dalziel & Tessa Peasgood & Tianxin Pan, 2025.
"How do Health State Values Differ When Respondents Consider Adults Versus Children Living in Those States? A Systematic Review,"
PharmacoEconomics, Springer, vol. 43(7), pages 723-740, July.
Handle:
RePEc:spr:pharme:v:43:y:2025:i:7:d:10.1007_s40273-025-01493-0
DOI: 10.1007/s40273-025-01493-0
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:pharme:v:43:y:2025:i:7:d:10.1007_s40273-025-01493-0. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.